ArticleOncoimmunology2015

Sunitinib depletes myeloid-derived suppressor cells and synergizes with a cancer vaccine to enhance antigen-specific immune responses and tumor eradication.

Oana Draghiciu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.